GlassScriptPhysician profile
John Winthrop Pierce
NPI 1134232887
$3,709.13
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,691 · 2020: $18.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $658.06 | 2019 | |
| Lilly USA, LLC | $501.49 | 2019 | |
| Novartis Pharmaceuticals Corporation | $341.41 | 2019 | |
| Amgen INC. | $316.64 | 2019 | |
| Amarin Pharma, INC. | $288.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $242.84 | 2019 | |
| Allergan, INC. | $239.30 | 2019 | |
| Glaxosmithkline, LLC. | $227.15 | 2019 | |
| Indivior INC. | $163.68 | 2019 | |
| Sanofi-Aventis U.S. LLC | $156.41 | 2019 | |
| Gilead Sciences, INC. | $82.43 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $76.48 | 2019 | |
| Sunovion Pharmaceuticals INC. | $63.91 | 2019-2020 | |
| Astellas Pharma US INC | $62.66 | 2019 | |
| Arbor Pharmaceuticals, INC. | $61.90 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $45.35 | 2019 | |
| Scilex Pharmaceuticals INC. | $41.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $40.21 | 2019 | |
| Horizon Therapeutics Plc | $37.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $33.68 | 2019 | |
| Pfizer INC. | $28.27 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.